Clinical Trial Update: DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants [Phase 3]

View source ↗

Summary

Phase 3 trial comparing primary and booster DTaP-IPV-Hib vaccinations to co-administration of DTaP-IPV and Hib in Japanese infants; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Neisseria Meningitidis Meningitis
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• DTaP-IPV vaccine
• DTaP-IPV-Hib vaccine (Diphtheria, Tetanus, acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae type b vaccine)
• Hib vaccine (Haemophilus influenzae type b vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Tetanus, Diphtheria | Phase 3 | Status: COMPLETED